دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0015-0282(23)01825-3
Volume 120, Issue 4, October 2023, Pages A4-A8
Can sperm quality affect reproductive outcomes?
Peter N. Schlegel, M.D.
doi : 10.1016/j.fertnstert.2023.08.007
Volume 120, Issue 4, October 2023, Pages 707-708
Can semen parameters predict pregnancy outcomes?
Dolores J. Lamb, Ph.D. and Jessica A. Marinaro, M.D.
doi : 10.1016/j.fertnstert.2023.06.035
Volume 120, Issue 4, October 2023, Pages 709-714
Sperm DNA fragmentation and its interaction with female factors
Jessica A. Marinaro, M.D.
doi : 10.1016/j.fertnstert.2023.06.001
Volume 120, Issue 4, October 2023, Pages 715-719
Sperm centriolar factors and genetic defects that can predict pregnancy
Philip Xie, B.S., a Olena M. Kocur, B.A., b Stephanie Cheung, M.S., a Lily Ng, B.S., a David F. Albertini, M.S., Ph.D., b Zev Rosenwaks, M.D., a and Gianpiero D. Palermo, M.D., Ph.D.
doi : 10.1016/j.fertnstert.2023.07.007
Volume 120, Issue 4, October 2023, Pages 720-728
Improving outcomes of assisted reproductive technologies using artificial intelligence for sperm selection
Nicole Lustgarten Guahmich, Ph.D., Elena Borini, M.Sc., and Nikica Zaninovic, Ph.D.
doi : 10.1016/j.fertnstert.2023.06.009
Volume 120, Issue 4, October 2023, Pages 729-734
The human edit
Sarah C. Cromack, M.D. Eve C. Feinberg, M.D.*
doi : 10.1016/j.fertnstert.2023.08.008
Volume 120, Issue 4, October 2023, Pages 735-736
Should we use CRISPR gene editing in human embryos?
Nada Kubikova, D.Phil., a,b David L. Keefe, M.D., c,d Dagan Wells, Ph.D., e,f Kutluk H. Oktay, M.D., Ph.D., g,h,i and Eve C. Feinberg, M.D.
doi : 10.1016/j.fertnstert.2023.08.009
Volume 120, Issue 4, October 2023, Pages 737-744
Reproductive endocrinology and infertility training: How long is long enough?
Marja Brolinson, M.D. a Eric A. Widra, M.D. b
doi : 10.1016/j.fertnstert.2023.08.018
Volume 120, Issue 4, October 2023, Page 745
Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole
Bryan D. Naelitz, M.S., M.D., a Tommy Jiang, B.A., b Carlos Munoz-Lopez, M.S., c John Tucker Sigalos, M.D., d Neilufar Modiri, B.S., b Rosella Cannarella, M.D., Ph.D.,a Jesse N. Mills, M.D., d Neel Parekh, M.D., a Amy S. Nowacki, Ph.D., e Sarah C. Vij, M.D., a Sriram V. Eleswarapu, M.D., Ph.D., d and Scott D. Lundy, M.D. Ph.D. a
doi : 10.1016/j.fertnstert.2023.06.032
Volume 120, Issue 4, October 2023, Pages 746-754
Meeting the demand for fertility services: the present and future of reproductive endocrinology and infertility in the United States
Eduardo Hariton, M.D., M.B.A., a Ruben Alvero, M.D., b,c Micah J. Hill, D.O., d Jennifer E. Mersereau, M.D., M.S.C.I., e Shana Perman, P.A., f,g David Sable, M.D., h Fiona Wang, P.A., i Geoffrey David Adamson, M.D., j Christos Coutifaris, M.D., Ph.D., k LaTasha B. Craig, M.D., l Pardis Hosseinzadeh, M.D., m Anthony N. Imudia, M.D., n Erica B. Johnstone, M.D., M.H.S., o Ruth B. Lathi, M.D., p Paul C. Lin, M.D., q,r Erica E. Marsh, M.D., M.S.C.I., s Michele Munch, C.R.N.P., t Gloria Richard-Davis, M.D., u Lauren W. Roth, M.D., v Amy K. Schutt, M.D., w,x Kim Thornton, M.D., y,z,aa Lauren Verrilli, M.D., M.S.C.I., o Rachel S. Weinerman, M.D., bb Steven L. Young, M.D., Ph.D., cc and Kate Devine, M.D.d,f,dd
doi : 10.1016/j.fertnstert.2023.08.019
Volume 120, Issue 4, October 2023, Pages 755-766
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndromeâ€
Helena J. Teede, a,b Chau Thien Tay,a,b Joop Laven, b,c Anuja Dokras, d Lisa J. Moran, a,b Terhi T. Piltonen, e Michael F. Costello, b,f Jacky Boivin, g Leanne M. Redman, h Jacqueline A. Boyle, b,i Robert. J. Norman, b,j Aya Mousa, a and Anju E. Joham a,b on behalf of the International PCOS Network
doi : 10.1016/j.fertnstert.2023.07.025
Volume 120, Issue 4, October 2023, Pages 767-793
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion
Practice Committee of the American Society for Reproductive Medicine
doi : 10.1016/j.fertnstert.2023.06.037
Volume 120, Issue 4, October 2023, Pages 794-801
Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion
Ethics Committee of the American Society for Reproductive Medicine
doi : 10.1016/j.fertnstert.2023.07.002
Volume 120, Issue 4, October 2023, Pages 802-809
Utilization of anastrazole in male infertility: potential for expanded use?
Nicholas A. Deebel, M.D. a Ranjith Ramasamy, M.D. b
doi : 10.1016/j.fertnstert.2023.07.023
Volume 120, Issue 4, October 2023, Page 810
The patient or the blastocyst; which leads to the perfect outcome prediction?
Carla Gim enez-Rodr?guez, M.Sc. a,b Marcos Meseguer, Ph.D.
doi : 10.1016/j.fertnstert.2023.08.011
Volume 120, Issue 4, October 2023, Pages 811-812
Müllerian anomalies: Co-conspirators or independent adversaries?
Meghan Yamasaki, D.O. a Phillip A. Romanski, M.D., M.Sc. b Benjamin S. Harris, M.D., M.P.H.
doi : 10.1016/j.fertnstert.2023.08.014
Volume 120, Issue 4, October 2023, Pages 813-814
Time for a paradigm shift
Jose Carugno, M.D. a Nash Moawad, M.D., M.S.b Emad Mikhail, M.D.
doi : 10.1016/j.fertnstert.2023.06.026
Volume 120, Issue 4, October 2023, Pages 815-816
Telehealth: disparity and disappointment
Aaron Huang, M.D. William T. Berg, M.D
doi : 10.1016/j.fertnstert.2023.06.036
Volume 120, Issue 4, October 2023, Pages 817-818
An “iron-clad� link between obesity and accelerated depletion of the ovarian reserve
Joshua Johnson, Ph.D.a Alex J. Polotsky, M.D. a,b
doi : 10.1016/j.fertnstert.2023.08.003
Volume 120, Issue 4, October 2023, Pages 819-820
Mandated fertility coverage: the resounding choice when morality, medicine, and money align
Sigal Klipstein, M.D. a Lee Rubin Collins, J.D.
doi : 10.1016/j.fertnstert.2023.08.017
Volume 120, Issue 4, October 2023, Pages 821-822
Timing of puberty in relation to semen characteristics, testicular volume, and reproductive hormones: a cohort study
Nis Brix, Ph.D., a,b Anne Gaml-S?rensen, Ph.D., a Andreas Ernst, Ph.D., a,c Linn H akonsen Arendt, Ph.D., a,d Lea Lykke Harrits Lunddorf, Ph.D., a Gunnar Toft, Ph.D., e Sandra S. T?ttenborg, Ph.D.,f,h Katia Keglberg H?rvig, Ph.D., f Birgit Bjerre H?yer, Ph.D., a,g Karin S. Hougaard, Ph.D., h,i Jens Peter E. Bonde, Ph.D., f,h and Cecilia H?st Ramlau-Hansen, Ph.D.
doi : 10.1016/j.fertnstert.2023.05.164
Volume 120, Issue 4, October 2023, Pages 823-833
Association between a morphokinetic ploidy prediction model risk score and miscarriage and live birth: a multicentre cohort study
Thomas Bamford, M.B., Ch.B, a,b Rachel Smith, B.Sc., b Christina Easter, M.Sc., a Rima Dhillon-Smith, Ph.D., a Amy Barrie, Ph,D., b Sue Montgomery, Ph.D., b Alison Campbell, Ph.D., b and Arri Coomarasamy, M.D.
doi : 10.1016/j.fertnstert.2023.06.006
Volume 120, Issue 4, October 2023, Pages 834-843
Reproductive inequity and inferior intrauterine insemination outcomes in patients with limited English proficiency: a retrospective cohort study
Meaghan Jain, M.D.,a Andrea Peterson, M.D., M.S.C.R.,a Nadia Nguyen, PhD,b and Michelle Goldsammler, M.D.
doi : 10.1016/j.fertnstert.2023.05.154
Volume 120, Issue 4, October 2023, Pages 844-849
Reproductive outcomes of oocyte donation in patients with uterine Müllerian anomalies
Elkin Mu~noz, M.D., Ph.D., a,b Iria Fern andez, M.D., a Nuria Pellicer, M.D., Ph.D., c Giulia Mariani, M.D., Ph.D., d Antonio Pellicer, M.D., Ph.D., d and Nicolas Garrido, Ph.D. e
doi : 10.1016/j.fertnstert.2023.06.029
Volume 120, Issue 4, October 2023, Pages 850-859
The developmental potential of mature oocytes derived from rescue in vitro maturation
Adi Kuperman Shani, M.D., a,b Lilach Marom Haham, M.D., a,b Hanna Balakier, Ph.D., a Iryna Kuznyetsova, Ph.D., a,c Siamak Bashar, Ph.D., a Erin N. Day, B.Sc., a and Clifford L. Librach, M.D. a,b,c,d,e,f
doi : 10.1016/j.fertnstert.2023.05.163
Volume 120, Issue 4, October 2023, Pages 860-869
Long-term risk of repeated surgeries in women managed for endometriosis: a 1,092 patient-series
Horace Roman, M.D., Ph.D., a,b Isabella Chanavaz-Lacheray, M.D., a Clotilde Hennetier, M.D., c Jean-Jacques Tuech, M.D., Ph.D., d Thomas Dennis, M.D., a Eric Verspyck, M.D., Ph.D., c and Benjamin Merlot, M.D.
doi : 10.1016/j.fertnstert.2023.05.156
Volume 120, Issue 4, October 2023, Pages 870-879
Racial disparities in telehealth use during the coronavirus disease 2019 pandemic
Surabhi Tewari, B.S., a Kathryn D. Coyne, M.D., b Rachel S. Weinerman, M.D., b Joseph Findley, M.D., b Sung Tae Kim, Ph.D., H.C.L.D., b and Rebecca L. R. Flyckt, M.D. b
doi : 10.1016/j.fertnstert.2023.05.159
Volume 120, Issue 4, October 2023, Pages 880-889
Effects of pulsatile intravenous follicle-stimulating hormone treatment on ovarian function in women with obesity
Thanh Ha Luu, M.D., a Katherine Kuhn, M.S., a Andrew P. Bradford, Ph.D., a Michael F. Wempe, Ph.D., b Luke Wittenburg, D.V.M., Ph.D., c Rachel L. Johnson, M.S., d Nichole E. Carlson, Ph.D., d T. Rajendra Kumar, Ph.D., a and Alex J. Polotsky, M.D.a,e
doi : 10.1016/j.fertnstert.2023.05.170
Volume 120, Issue 4, October 2023, Pages 890-898
The transcriptome reveals the molecular regulatory network of primordial follicle depletion in obese mice
Jiaqi Zhou, Ph.D., a Lin Lin, Ph.D., a Longping Liu, Ph.D., b Jianbin Wang, Ph.D., b Guoliang Xia, Ph.D., a,c and Chao Wang, Ph.D. a
doi : 10.1016/j.fertnstert.2023.05.165
Volume 120, Issue 4, October 2023, Pages 899-910
Impact of in vitro fertilization insurance coverage in mandated vs. nonmandated states in the United States before 2017
Michelle Kappy, M.D. a, * Marlena Plagianos, M.S.b Julian Gingold, M.D., Ph.D. c Sangita Jindal, Ph.D.d Susan Klugman, M.D. f Harry Lieman, M.D.
doi : 10.1016/j.fertnstert.2023.07.005
Volume 120, Issue 4, October 2023, Pages 911-913
Trends in infertility prevalence and treatment seeking in the United States: Results from the National Survey of Family Growth 1995 through 2017–2019
Katherine I. Tierney, Ph.D.a Arthur L. Greil, Ph.D.b Ann V. Bell, Ph.D.
doi : 10.1016/j.fertnstert.2023.07.006
Volume 120, Issue 4, October 2023, Pages 914-916
Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis
Tamara N. Ram?rez-Pavez, M.Sc., a Francisco Machado-Linde, M.D., Ph.D., b Pilar Garc?a-Pe~narrubia, M.D., Ph.D., a Luc?a Nieto-Meca, M.D., c Mar?a Mart?nez-Esparza, Ph.D., a and Pilar Mar?n-S anchez, M.D., Ph.D.
doi : 10.1016/j.fertnstert.2023.06.030
Volume 120, Issue 4, October 2023, Pages 917-919
Diagnostic considerations and surgical techniques for a large prolapsing submucosal myoma
Angelina Carey-Love, M.D., a Linda Bradley, M.D., a and Rosanne M. Kho, M.D. b
doi : 10.1016/j.fertnstert.2023.07.009
Volume 120, Issue 4, October 2023, Pages 920-921
Treatment of uterine scar cystoid diverticulum by hysteroscopy combined with laparoscopy
Yanan Wang, M.M., a Xianhua Hao, M.B.B.S., b Yahui Chen, M.M., a Lin Wang, M.M., a Yan Zhou, M.M., a Mei Xue, M.M., a Yan Dong, M.M., a,c and Lin Sun, M.D. b
doi : 10.1016/j.fertnstert.2023.07.013
Volume 120, Issue 4, October 2023, Pages 922-924
Letter to “A day in the life of a reproductive endocrinologist and infertility subspecialist—integration or dissolution?�
Marco Mouanness, M.D. a Zaher Merhi, M.D., H.C.L.D
doi : 10.1016/j.fertnstert.2023.08.002
Volume 120, Issue 4, October 2023, Page 925
Reply of the author: “A day in the life of a reproductive endocrinologist and infertility subspecialist—integration or dissolution?�
Nanette Santoro, M.D.*
doi : 10.1016/j.fertnstert.2023.08.016
Volume 120, Issue 4, October 2023, Page 926
Local intraendometrial estrogen biosynthesis leading to progesterone resistance impacts implantation in adenomyosis and endometriosis
Peter Humaidan, M.D., D.M.Sc.a,b Juan Antonio Garcia Velasco, M.D., Ph.D.c,d Mauro Cozzolino, M.D. e,f
doi : 10.1016/j.fertnstert.2023.06.004
Volume 120, Issue 4, October 2023, Page 927
Reply of the authors: Endometrial receptivity in adenomyosis and/or endometriosis
Paul Pirtea, M.D.* Dominique de Ziegler, M.D. Jean Marc Ayoubi, Ph.D., M.D.
doi : 10.1016/j.fertnstert.2023.07.015
Volume 120, Issue 4, October 2023, Page 928
Need to redefine letrozole resistance in polycystic ovary syndrome: understanding the concept of follicle-stimulating hormone threshold and window
Bhanupriya SB, M.D. Radha Rani Seelam, M.B.B.S. Juhi Bharti, M.S.
doi : 10.1016/j.fertnstert.2023.06.033
Volume 120, Issue 4, October 2023, Page 929
